Bio-Rad Laboratories PE Ratio 2010-2025 | BIO
Current and historical p/e ratio for Bio-Rad Laboratories (BIO) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bio-Rad Laboratories PE ratio as of June 17, 2025 is 21.94.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Bio-Rad Laboratories PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-17 | 230.46 | 0.00 | |
| 2025-03-31 | 243.56 | $-76.20 | 0.00 |
| 2024-12-31 | 328.51 | $-65.04 | 0.00 |
| 2024-09-30 | 334.58 | $-27.33 | 0.00 |
| 2024-06-30 | 273.11 | $-47.03 | 0.00 |
| 2024-03-31 | 345.87 | $-10.36 | 0.00 |
| 2023-12-31 | 322.89 | $-21.49 | 0.00 |
| 2023-09-30 | 358.45 | $-5.85 | 0.00 |
| 2023-06-30 | 379.12 | $-15.01 | 0.00 |
| 2023-03-31 | 479.02 | $-6.54 | 0.00 |
| 2022-12-31 | 420.49 | $-121.43 | 0.00 |
| 2022-09-30 | 417.14 | $-201.80 | 0.00 |
| 2022-06-30 | 495.00 | $-66.32 | 0.00 |
| 2022-03-31 | 563.23 | $-4.88 | 0.00 |
| 2021-12-31 | 755.57 | $140.07 | 5.39 |
| 2021-09-30 | 745.95 | $220.47 | 3.38 |
| 2021-06-30 | 644.29 | $134.15 | 4.80 |
| 2021-03-31 | 571.17 | $135.98 | 4.20 |
| 2020-12-31 | 582.94 | $126.32 | 4.61 |
| 2020-09-30 | 515.46 | $116.82 | 4.41 |
| 2020-06-30 | 451.49 | $64.50 | 7.00 |
| 2020-03-31 | 350.56 | $52.21 | 6.71 |
| 2019-12-31 | 370.03 | $58.23 | 6.35 |
| 2019-09-30 | 332.74 | $12.04 | 27.64 |
| 2019-06-30 | 312.59 | $29.61 | 10.56 |
| 2019-03-31 | 305.68 | $18.62 | 16.42 |
| 2018-12-31 | 232.22 | $11.65 | 19.93 |
| 2018-09-30 | 312.99 | $41.85 | 7.48 |
| 2018-06-30 | 288.54 | $33.87 | 8.52 |
| 2018-03-31 | 250.08 | $25.17 | 9.94 |
| 2017-12-31 | 238.67 | $3.81 | 62.64 |
| 2017-09-30 | 222.22 | $0.79 | 281.29 |
| 2017-06-30 | 226.31 | $0.50 | 452.62 |
| 2017-03-31 | 199.34 | $0.94 | 212.06 |
| 2016-12-31 | 182.28 | $0.95 | 191.87 |
| 2016-09-30 | 163.81 | $3.33 | 49.19 |
| 2016-06-30 | 143.02 | $3.30 | 43.34 |
| 2016-03-31 | 136.72 | $3.66 | 37.36 |
| 2015-12-31 | 138.66 | $3.85 | 36.02 |
| 2015-09-30 | 134.31 | $3.51 | 38.26 |
| 2015-06-30 | 150.61 | $3.31 | 45.50 |
| 2015-03-31 | 135.18 | $3.43 | 39.41 |
| 2014-12-31 | 120.56 | $3.05 | 39.53 |
| 2014-09-30 | 113.40 | $2.75 | 41.24 |
| 2014-06-30 | 119.71 | $2.11 | 56.73 |
| 2014-03-31 | 128.12 | $2.22 | 57.71 |
| 2013-12-31 | 123.61 | $2.67 | 46.30 |
| 2013-09-30 | 117.56 | $3.28 | 35.84 |
| 2013-06-30 | 112.20 | $5.01 | 22.40 |
| 2013-03-31 | 126.00 | $5.50 | 22.91 |
| 2012-12-31 | 105.05 | $5.91 | 17.77 |
| 2012-09-30 | 106.72 | $6.34 | 16.83 |
| 2012-06-30 | 100.01 | $6.47 | 15.46 |
| 2012-03-31 | 103.69 | $6.19 | 16.75 |
| 2011-12-31 | 96.04 | $6.26 | 15.34 |
| 2011-09-30 | 90.77 | $6.59 | 13.77 |
| 2011-06-30 | 119.36 | $6.57 | 18.17 |
| 2011-03-31 | 120.14 | $6.51 | 18.45 |
| 2010-12-31 | 103.85 | $6.59 | 15.76 |
| 2010-09-30 | 90.51 | $5.53 | 16.37 |
| 2010-06-30 | 86.49 | $5.32 | 16.26 |
| 2010-03-31 | 103.52 | $5.34 | 19.39 |
| 2009-12-31 | 96.46 | $5.20 | 18.55 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.175B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.957B | 28.04 |
| Boston Scientific (BSX) | United States | $147.560B | 37.59 |
| Stryker (SYK) | United States | $144.011B | 30.10 |
| EssilorLuxottica (ESLOY) | France | $128.708B | 0.00 |
| Medtronic (MDT) | Ireland | $111.928B | 15.99 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.371B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.904B | 27.49 |
| ResMed (RMD) | United States | $36.560B | 27.72 |
| Agilent Technologies (A) | United States | $33.258B | 22.04 |
| GE HealthCare Technologies (GEHC) | United States | $33.082B | 15.84 |
| Terumo (TRUMY) | Japan | $26.680B | 34.37 |
| Insulet (PODD) | United States | $21.438B | 84.69 |
| Koninklijke Philips (PHG) | Netherlands | $21.384B | 15.43 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.060B | 11.71 |
| Baxter (BAX) | United States | $15.713B | 11.81 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.872B | 0.00 |
| Demant (WILYY) | Denmark | $9.377B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.385B | 13.58 |
| Prestige Consumer Healthcare (PBH) | United States | $4.149B | 18.47 |
| Perrigo (PRGO) | Ireland | $3.664B | 9.30 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.367B | 15.31 |
| ICU Medical (ICUI) | United States | $3.250B | 24.18 |
| Envista Holdings (NVST) | United States | $3.127B | 26.73 |
| GN Store Nord (GNNDY) | Denmark | $2.263B | 19.32 |
| QuidelOrtho (QDEL) | United States | $1.954B | 13.59 |
| LeMaitre Vascular (LMAT) | United States | $1.833B | 41.46 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Acuren (TIC) | United States | $1.357B | 0.00 |
| Neogen (NEOG) | United States | $1.200B | 15.67 |
| AdaptHealth (AHCO) | United States | $1.161B | 11.81 |
| Green Thumb Industries (GTBIF) | United States | $1.048B | 23.71 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.970B | 12.80 |
| Kestra Medical Technologies (KMTS) | United States | $0.904B | 0.00 |
| InMode (INMD) | Israel | $0.844B | 8.55 |
| Evolus (EOLS) | United States | $0.640B | 0.00 |
| CeriBell (CBLL) | United States | $0.624B | 0.00 |
| Owens & Minor (OMI) | United States | $0.602B | 5.08 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.538B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.524B | 0.00 |
| Valneva SE (VALN) | France | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.407B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 12.53 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.329B | 61.50 |
| Canopy Growth (CGC) | Canada | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.50 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.253B | 11.63 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.207B | 6.12 |
| Brainsway (BWAY) | Israel | $0.206B | 55.30 |
| Omeros (OMER) | United States | $0.199B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Organigram Global (OGI) | Canada | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.140B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 15.33 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.37 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Agape ATP (ATPC) | $0.084B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 48.64 |
| United-Guardian (UG) | United States | $0.037B | 13.19 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Safety Shot (SHOT) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.012B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |